DCF — INOVA FAIRFAX HOSPITAL
Enterprise Value: $1.5B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$1.5B
Enterprise Value
$391.0M
PV of Cash Flows
$1.1B
PV of Terminal Value
$1.8B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $2.5B | $211.0M | 9.0% | $68.7M | $62.4M |
| Year 2 | $2.6B | $242.9M | 10.0% | $89.9M | $74.3M |
| Year 3 | $2.6B | $276.5M | 11.0% | $112.4M | $84.4M |
| Year 4 | $2.7B | $298.4M | 11.0% | $125.9M | $86.0M |
| Year 5 | $2.8B | $314.3M | 11.0% | $134.9M | $83.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $1.5B. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$2.4B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000016595521
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5